TY - STD TI - Baygi F, Jensen OC, Qorbani M, Farshad AA, Salehi SA, Mohammadi-Nasrabadi F, Asayesh H, Shidfar F. Prevalence and associated factors of cardio-metabolic risk factors in Iranian seafarers. Int Marit Health. 2016;67(2):59–65. https://doi.org/10.5603/IMH.2016.0013. ID - ref1 ER - TY - STD TI - Cornier MA, Dabelea D, Hernandez TL, et al. The metabolic syndrome. Endocr Rev. 2008;29:777–822. https://doi.org/10.1210/er.2008-0024. ID - ref2 ER - TY - JOUR AU - Jeppesen, J. AU - Hansen, T. W. AU - Rasmussen, S. AU - Ibsen, H. AU - Torp-Pedersen, C. AU - Madsbad, S. PY - 2007 DA - 2007// TI - Insulin resistance, the metabolic syndrome, and risk of incident cardiovascular disease. A population-based study JO - J Am Coll Cardiol VL - 49 UR - https://doi.org/10.1016/j.jacc.2007.01.088 DO - 10.1016/j.jacc.2007.01.088 ID - Jeppesen2007 ER - TY - STD TI - Romaguera JOA, Roca FJ, Colo´n G, Sua´rez E. Factors associated with metabolic syndrome in a sample of women in Puerto Rico. Menopause. 2010;17(2):388–92. https://doi.org/10.1097/gme.0b013e3181bd5393. ID - ref4 ER - TY - STD TI - Moy FM, Bulgiba A. The modified NCEP ATP III criteria maybe better than the IDF criteria in diagnosing metabolic syndrome among Malays in Kuala Lum-pur. BMC Public Health. 2010;10(1):678. https://doi.org/10.1186/1471-2458-10-678. ID - ref5 ER - TY - STD TI - Pedersen SF, Jepsen JR. The metabolic syndrome among Danish seafarers. Int Marit Health. 2013;64:183–90. ID - ref6 ER - TY - STD TI - Eckel RH, Grundy S, Zimmet P. The metabolic syndrome. Lancet. 2005;365:1415–28. https://doi.org/10.1016/S0140-6736(05)66378-7. ID - ref7 ER - TY - STD TI - Kawada T. Insulin-related biomarkers to predict the risk of metabolic syndrome. Int J Endocrinol Metab. 2013;11(4):e10418. https://doi.org/10.5812/ijem.10418. ID - ref8 ER - TY - STD TI - Kang YH, Min HG, Kim IJ, Kim YK, Son SM. Comparison of alanine aminotransferase, white blood cell count, and uric acid in their association with metabolic syndrome: a study of Korean adults. Endocr J. 2008;55(6):1093–102. ID - ref9 ER - TY - STD TI - Babio NI-JN, Bulló M, Martínez-González MÁ, Wärnberg J, et al. White blood cell counts as risk markers of developing metabolic syndrome and its components in the PREDIMED study. PLoS One. 2013;8(3):e58354. https://doi.org/10.1371/journal.pone.0058354. ID - ref10 ER - TY - STD TI - Kunutsor SK, Seddoh D. Alanine aminotransferase and risk of the metabolic syndrome: a linear dose-response relationship. PLoS One. 2014;9(4):e96068. https://doi.org/10.1371/journal.pone.0096068. ID - ref11 ER - TY - STD TI - Lee JM, Kim HC, Cho HM, Oh SM, Choi DP, Suh I. Association between serum uric acid level and metabolic syndrome. J Prev Med Public Health. 2012;45(3):181–7. https://doi.org/10.3961/jpmph.2012.45.3.181. ID - ref12 ER - TY - STD TI - Yang T, Chu CH, Bai CH, You SL, Chou YC, Hwang LC, et al. Uric acid concentration as a risk marker for blood pressure progression and incident hypertension: a Chinese cohort study. Metabolism. 2012;61(12):1747–55. https://doi.org/10.1016/j.metabol.2012.05.006. ID - ref13 ER - TY - STD TI - Niskanen L, Laaksonen DE, Nyyssonen K, et al. SUA level as a risk factor for cardiovascular and all-cause mortality in middle-aged men: a prospective cohort study. Arch Intern Med. 2004;164:1546–51. https://doi.org/10.1001/archinte.164.14.1546. ID - ref14 ER - TY - STD TI - Iwashima Y, Horio T, Kamide K, Rakugi H, Ogihara T, Kawano Y. Uric Acid, Left Ventricular Mass Index, and Risk of Cardiovascular Disease in Essential ypertension. Hypertension. 2006;47:195–202. https://doi.org/10.1161/01.HYP.0000200033.14574.14. ID - ref15 ER - TY - STD TI - Lippi G, Montagnana M, Luca Salvagno G, Targher G, Cesare Guidi G. Epidemiological Association between Uric Acid Concentration in Plasma, Lipoprotein(a), and the Traditional Lipid Profile. Clin Cardiol. 2010;33(2):E76–80. https://doi.org/10.1002/clc.20511. ID - ref16 ER - TY - STD TI - Stelmach MJ, Wasilewska N, Wicklund-Liland LI, Wasilewska A. Blood lipid profile and BMI-Z-score in adolescents with hyperuricemia. Ir J Med Sci. 2015;184:463–8. https://doi.org/10.1007/s11845-014-1146-8. ID - ref17 ER - TY - STD TI - Krzystek-Korpacka MPE, Kustrzeba-Wojcicka I, Chrzanowska J, Gamian A, Noczynska A. Gender-specific association of SUA with MetS and its components in juvenile obesity. Clin Chem Lab Med. 2011;49:129–36. ID - ref18 ER - TY - STD TI - Wilson PW, D' Agostine RB, Parise H, Sullivan L, Meigs JB. Metabolic syndrome as a precursor of cardiovascular disease and type 2 diabetes mellitus. Circulation. 2005;112:3066–72. https://doi.org/10.1161/CIRCULATIONAHA.105.539528. ID - ref19 ER - TY - STD TI - Hsieh FY, Block DA, Larsen MD. A simple method of sample size calculation for linear and logistic Regression', statistics in Medicine, vol. 17; 1998. p. 1623–34. https://doi.org/10.1002/(SICI)1097-0258(19980730)17:14<1623::AID-SIM871>3.0.CO;2-S. ID - ref20 ER - TY - JOUR AU - Aryan, Z. AU - Mahmoudi, N. AU - Sheidaei, A. AU - Rezaei, S. AU - Mahmoudi, Z. AU - Gohari, K. AU - Rezaei, N. AU - Hajipour, M. J. AU - Dilmaghani-Marand, A. AU - Razi, F. AU - Sabooni, M. PY - 2018 DA - 2018// TI - The prevalence, awareness, and treatment of lipid abnormalities in Iranian adults: surveillance of risk factors of noncommunicable diseases in Iran 2016 JO - J Clin Lipidol VL - 12 UR - https://doi.org/10.1016/j.jacl.2018.08.001 DO - 10.1016/j.jacl.2018.08.001 ID - Aryan2018 ER - TY - STD TI - Azizi F, Hadaegh F, Khalili D, Esteghamati A, Hosseinpanah F, Delavari A, et al. Appropriate definition of metabolic syndrome among Iranian adults: report of the Iranian National Committee of Obesity. Arch Iran Med. 2010;13:426. https://doi.org/10.10135/AIM.0011. ID - ref22 ER - TY - STD TI - Cardoso ASGN, Medeiros CC, Carvalho DF. Association ofSUA levels with components of MetS and non-alcoholic fatty liver disease in overweight or obese children and adolescents. J Pediatr. 2013;89:412–8. ID - ref23 ER - TY - JOUR AU - Rathmann, W. F. E. AU - Dyer, A. R. AU - Roseman, J. M. PY - 1998 DA - 1998// TI - Relations of hyperuricemia with the various components of the insulin resistance syndrome in young black and white adults: the CARDIA Study JO - Ann Epidemiol VL - 8 UR - https://doi.org/10.1016/S1047-2797(97)00204-4 DO - 10.1016/S1047-2797(97)00204-4 ID - Rathmann1998 ER - TY - JOUR AU - Wang, H. J. AU - Shi, L. Z. AU - Liu, C. F. AU - Liu, S. M. AU - Shi, S. T. PY - 2018 DA - 2018// TI - Association between uric acid and metabolic syndrome in elderly women JO - OPEN MEDICINE VL - 13 UR - https://doi.org/10.1515/med-2018-0027 DO - 10.1515/med-2018-0027 ID - Wang2018 ER - TY - STD TI - Shi-Dou Lin D-HT, Hsu S-R. Association Between Serum Uric Acid Level and Components of the Metabolic Syndrome. J Chin Med Assoc. 2006;69(11). https://doi.org/10.1016/S1726-4901(09)70320-X. ID - ref26 ER - TY - STD TI - Safiri S, Qorbani M, Heshmat R, Tajbakhsh R, Eslami Shahr Babaki A, Djalalinia SH. Association of serum uric acid with cardiometabolic risk factors and metabolic syndrome in Iranian adolescents. The CASPIAN-III Study. IJKD. 2016;10:126–34. ID - ref27 ER - TY - STD TI - Yoo TW, Sung KC, Shin SH, Kim BJ, Kim BS, Kang JH. Relationship between serum uric acid concentration and insulin resistance and metabolic syndrome. Circ J. 2005;69:928–33. ID - ref28 ER - TY - STD TI - Zhu P, Liu Y, Han L, Xu G, Ran J-M. Serum uric acid is associated with incident chronic kidney disease in middle-aged populations: a meta-analysis of 15 cohort studies. PLoS One. 2014;9(6):e100801. https://doi.org/10.1371/journal.pone.0100801. ID - ref29 ER - TY - STD TI - DI. F. Hyperuricemia and hypertension. Adv Chronic Kidney Dis. 2012;19(6):377–85. https://doi.org/10.1053/j.ackd.2012.05.009. ID - ref30 ER - TY - STD TI - Cannella AC, Mikuls TR. Understanding treatments for gout. Am J Manag Care. 2005;11(suppl 15):S451–S8. ID - ref31 ER - TY - STD TI - Schlesinger N. Dietary factors and hyperuricaemia. Curr Pharm Des. 2005;11:4133–8. https://doi.org/10.2174/138161205774913273. ID - ref32 ER - TY - STD TI - Khichar S, Choudhary S, Singh VB, Tater P, Arvinda RV, Ujjawal V. Serum uric acid level as a determinant of the metabolic syndrome: a case control study. Diab Metabol Syndr. 2016;11(1):19–23. https://doi.org/10.1016/j.dsx.2016.06.021. ID - ref33 ER - TY - STD TI - Chen Y-Y, Chen W-L, Kao T-W, Yang H-F, Chou C-W, Wu C-J, et al. The association of uric acid with the risk of metabolic syndrome, arterial hypertension or diabetes in young subjects- an observational study. Clin Chim Acta. 2018;478:68–73. https://doi.org/10.1016/j.cca.2017.12.038. ID - ref34 ER - TY - STD TI - Meshkani R, Zargari M, Larijani B. The relationship between uric acid and metabolic syndrome in normal glucose tolerance and normal fasting glucose subjects. Acta Diabetol. 2011;48(1):79–88. https://doi.org/10.1007/s00592-010-0231-3. ID - ref35 ER - TY - STD TI - Yang T, Chu C-H, Bai C-H, You S-L, Chou Y-C, Chou W-Y, et al. Uric acid level as a risk marker for metabolic syndrome: a Chinese cohort study. Atherosclerosis. 2011;220(2):525–31. https://doi.org/10.1016/j.atherosclerosis.2011.11.014. ID - ref36 ER - TY - JOUR AU - Culleton, B. F. L. M. AU - Kannel, W. B. AU - Levy, D. PY - 1999 DA - 1999// TI - Serum uric acid and risk for cardiovascular disease and death: the Framingham Heart Study JO - Ann Intern Med VL - 131 UR - https://doi.org/10.7326/0003-4819-131-1-199907060-00003 DO - 10.7326/0003-4819-131-1-199907060-00003 ID - Culleton1999 ER - TY - STD TI - Nejatinamini S, Ataie-Jafari A, Qorbani M, Nikoohemat SH, Kelishadi R, Asayesh H, Hosseini S. Association between serum uric acid level and metabolic syndrome components. J Diab Metabol Disord. 2015;14:70. https://doi.org/10.1186/s40200-015-0200-z. ID - ref38 ER - TY - STD TI - Zhang Q, Zhang CH, Song X, Lin H, Zhan D, Meng W, et al. A longitudinal cohort based association study between uric acid level and metabolic syndrome in Chinese Hanurban male population. BMC Public Health. 2012;12:419. https://doi.org/10.1186/1471-2458-12-419. ID - ref39 ER - TY - STD TI - Ryu S, Song J, Choi BY, Lee SJ, Kim DI, Chang Y, et al. Incidence and risk factors for metabolic syndrome in Korean male workers, ages 30 to 39. Ann Epidemiol. 2007;17(4):245–52. https://doi.org/10.1016/j.annepidem.2006.10.001. ID - ref40 ER - TY - STD TI - Sui X, Church TS, Meriwether RA, Lobelo F, Blair SN. Uric acid and the development of metabolic syndrome in women and men. Metabolism. 2008;57(6):845–52. https://doi.org/10.1016/j.metabol.2008.01.030. ID - ref41 ER - TY - STD TI - Norvik JV, Storhaug HM, Ytrehus K, Jenssen TG, Zykova SN, Eriksen BO. Overweight modifies the longitudinal association between uric acid and some components of the metabolic syndrome: the Tromsø study. BMC Cardiovasc Disord. 2016;16:85. https://doi.org/10.1186/s12872-016-0265-8. ID - ref42 ER - TY - STD TI - Billiet L, Doaty S, Katz JD, Velasquez MT. Review of hyperuricemia as new marker for metabolic syndrome. ISRN Rheumatol. 2014;2014:852954–7. https://doi.org/10.1155/2014/852954. ID - ref43 ER - TY - STD TI - Yuan H, Yu C, Li X, Sun L, Zhu X, Zhao C, et al. Serum uric acid levels and risk of metabolic syndrome: a dose-response meta-analysis of prospective studies. J Clin Endocrinol Metab. 2015;100(11):4198–207. https://doi.org/10.1210/jc.2015-2527. ID - ref44 ER - TY - STD TI - Srikanthan K, Feyh A, Visweshwar H, Shapiro JI, Sodhi K. Systematic review of metabolic syndrome biomarkers: a panel for early detection, management, and risk stratification in the west Virginian population. Int J Med Sci. 2016;13(1):25–38. https://doi.org/10.7150/ijms.13800. ID - ref45 ER -